$436.61
+7.44
(+1.73%)
As of Oct 15, 2026, 12:48 AM EDT
Price history
Today's analyst average
Analyst average over timeIndividual analyst targets
Analyst history starts Aug 5, 2026, the first target we tracked for WAT.
Waters Corporation (WAT) is trading up at $436.61 (+1.73%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Analyst price targets on WAT
One firm's current price target on Waters Corporation: $475 — 9% above the current $437. Each is tracked to its date and scored the same way a member's call is.
- TD Cowen $400 → $475 by Aug 2027 Aug 5, 2026 via Investing.com · TD Cowen's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
Waters Corporation revenue & net income history (FY2016–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.17B | $2.31B | $2.42B | $2.41B | $2.37B | $2.79B | $2.97B | $2.96B | $2.96B | $3.17B |
| Growth (year over year) | +6.1% | +6.5% | +4.8% | −0.6% | −1.7% | +17.8% | +6.7% | −0.5% | +0.1% | +7.0% |
| Gross profit | $1.28B | $1.36B | $1.43B | $1.40B | $1.36B | $1.63B | $1.72B | $1.76B | $1.76B | $1.88B |
| Gross margin | 58.9% | 59.0% | 59.0% | 58.0% | 57.4% | 58.5% | 58.0% | 59.6% | 59.4% | 59.3% |
| Operating income | $625.0M | $662.2M | $739.8M | $708.5M | $645.5M | $821.7M | $873.4M | $817.7M | $826.4M | $802.6M |
| Operating margin | 28.8% | 28.7% | 30.6% | 29.4% | 27.3% | 29.5% | 29.4% | 27.7% | 27.9% | 25.4% |
| Net income | $521.5M | $20.3M | $593.8M | $592.2M | $521.6M | $692.8M | $707.8M | $642.2M | $637.8M | $642.6M |
| Net margin | 24.1% | 0.9% | 24.5% | 24.6% | 22.1% | 24.9% | 23.8% | 21.7% | 21.6% | 20.3% |
| EPS (diluted) | $6.41 | $0.25 | $7.65 | $8.69 | $8.36 | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |
| Balance sheet | ||||||||||
| Cash and equivalents | $505.6M | $642.3M | $796.3M | $335.7M | $436.7M | $501.2M | $480.5M | $395.1M | $325.4M | $588.0M |
| Total assets | $4.66B | $5.32B | $3.73B | $2.56B | $2.84B | $3.09B | $3.28B | $4.63B | $4.55B | $5.08B |
| Total liabilities | $2.36B | $3.09B | $2.16B | $2.77B | $2.61B | $2.73B | $2.78B | $3.48B | $2.73B | $2.52B |
| Long-term debt | $1.70B | $1.90B | $1.15B | $1.58B | $1.21B | $1.51B | $1.52B | $2.31B | $1.63B | $947.0M |
| Shareholders' equity | $2.30B | $2.23B | $1.57B | −$216.3M | $232.1M | $367.6M | $504.5M | $1.15B | $1.83B | $2.56B |
| Cash flow | ||||||||||
| Operating cash flow | $642.9M | $697.6M | $604.4M | $643.1M | $790.5M | $747.3M | $611.7M | $602.8M | $762.1M | $652.6M |
| Capital expenditure | — | — | — | — | — | — | — | $160.6M | $142.5M | $112.7M |
| Free cash flow | — | — | — | — | — | — | — | $442.2M | $619.6M | $539.8M |
| Share buybacks | $325.8M | $332.5M | $1.32B | $2.47B | $196.4M | $648.9M | $626.1M | $70.3M | $13.5M | $14.7M |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Apr 2026 | Q2 FY26Jul 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $740.3M | $872.7M | $662.0M | $771.0M | $799.9M | $932.4M | $1.27B | $1.65B |
| Growth (year over year) | +4.0% | +6.5% | +4.0% | +8.8% | +8.0% | +6.8% | +91.4% | +113.4% |
| Gross profit | $438.6M | $524.2M | $385.3M | $449.6M | $472.1M | $569.5M | — | — |
| Gross margin | 59.3% | 60.1% | 58.2% | 58.3% | 59.0% | 61.1% | — | — |
| Operating income | $211.1M | $292.3M | $152.0M | $188.0M | $192.1M | $270.5M | −$47.0M | −$86.0M |
| Operating margin | 28.5% | 33.5% | 23.0% | 24.4% | 24.0% | 29.0% | −3.7% | −5.2% |
| Net income | $161.5M | $231.4M | $121.0M | $147.0M | $148.9M | $225.7M | −$72.0M | −$136.0M |
| Net margin | 21.8% | 26.5% | 18.3% | 19.1% | 18.6% | 24.2% | −5.7% | −8.3% |
| EPS (diluted) | $2.71 | $3.88 | $2.03 | $2.47 | $2.50 | $3.76 | −$0.87 | −$1.39 |
| Balance sheet | ||||||||
| Cash and equivalents | $330.5M | $325.4M | $382.9M | $367.2M | $459.1M | $588.0M | $462.0M | $539.0M |
| Total assets | $4.51B | $4.55B | $4.59B | $4.72B | $4.86B | $5.08B | $24.5B | $24.8B |
| Total liabilities | $2.91B | $2.73B | $2.63B | $2.56B | $2.53B | $2.52B | $9.24B | $9.56B |
| Long-term debt | $1.83B | $1.63B | $1.36B | $1.20B | $947.2M | $947.0M | $4.86B | $4.89B |
| Shareholders' equity | $1.60B | $1.83B | $1.96B | $2.16B | $2.33B | $2.56B | $15.3B | $15.2B |
| Cash flow | ||||||||
| Operating cash flow | $204.6M | $240.1M | $260.0M | $41.0M | $187.0M | $164.6M | −$3.00M | $201.0M |
| Capital expenditure | — | — | $26.0M | $23.0M | — | — | $39.0M | $48.0M |
| Free cash flow | — | — | $234.0M | $18.0M | — | — | −$42.0M | $153.0M |
| Share buybacks | $141.0K | $66.0K | $14.0M | $0 | $523.0K | $144.0K | $12.0M | $2.00M |
From Waters Corporation's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Waters Corporation
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries.
Source: Wikipedia — Waters Corporation
- Headquarters
- Milford, Massachusetts From SEC filings, Oct 2026
Recent News (20)
-
PRIMO BRANDS OPENS NEW MOUNTAIN VALLEY FACTORY AS DEMAND GROWS First new facility since the creation of Primo Brands in 2024 expands capacity for one of America's fastest-growing premium spring waters, sourced and bottled in Arkansas since 1871 HOT SPRINGS, Ark.,…
-
Treat Yourself With Hint's New Dessert-Flavored Waters The limited-edition Key Lime Pie, Strawberry Cupcake, Pineapple Whip and Berry Cobbler flavors deliver everyday indulgence—with zero calories, sugar or sweeteners. SAN FRANCISCO, Oct. 14, 2026 /PRNews…
-
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumables Le…
-
Hegseth greets ship returning from troubled waters Plus: 🏒Ovechkin’s final home opener in DC {beacon} It’s Wednesday, and there is no shortage of news coming to us today... In today's issue: Hegseth greets crew from USS Abraham Lincoln Hinson and …
-
-
Robust Results Lifted Waters (WAT)
Robust Results Lifted Waters (WAT)
-
Burnham navigates diplomatic rapids in first Trump meeting, but turbulent waters lie ahead
British aides express relief, as the prime minister’s team say the meeting was at the ‘top end of their expectations’
On the flight out to New York this week, one of Andy Burnham’s senior aides warned…
-
Hung Cao's bid for Navy secretary faces choppy waters post-USS Abraham Lincoln President Trump’s official nomination of Hung Cao to be Navy secretary is already in jeopardy after Democratic senators indicated they won’t vote in favor of giving him the waiver needed to serve. Cao…
-
-
How Is Waters Corporation's Stock Performance Compared to Other Health Care Stocks?
How Is Waters Corporation's Stock Performance Compared to Other Health Care Stocks?
-
Waters Corporation stock hits 52-week high at 427.1 USD
Waters Corporation stock hits 52-week high at 427.1 USD
-
-
Waters launches BD FACSDiscover A7 cell analyzer globally
Waters launches BD FACSDiscover A7 cell analyzer globally
-
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user difference…
-
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user difference…
-
Maine’s lobster industry finds itself squeezed on all sides amid Canada trade war STONINGTON, MAINE — The Maine lobster business has found itself in the crosshairs of a trade war and congressional infighting as rising costs and other pressures leave the heritage industry in a preca…
-
Global Times: Silk Road Maritime shipping routes span 153 ports, boosting global trade prosperity amid uncertainty BEIJING, Sept. 12, 2026 /PRNewswire/ -- Across the rippling Baltic waters, a cargo vessel loaded with Chinese goods glides steadily into Poland's Gdansk Port, docking at Europe's largest deep-water co…
-
-
-
More Health Care stocks
- UNH UnitedHealth Group
- VEEV Veeva Systems
- VRTX Vertex Pharmaceuticals
- VTRS Viatris
- WST West Pharmaceutical Services
- ZBH Zimmer Biomet
- ZTS Zoetis
- A Agilent Technologies